Market Research Logo

North America Antidepressants Drugs, Devices And Therapies Market Forecast 2019-2027

North America Antidepressants Drugs, Devices And Therapies Market Forecast 2019-2027

KEY FINDINGS

The North American region is one the largest antidepressants drugs, devices, and therapies by diagnosed patients, devices manufacturers and establishment of several psychiatrists and psychologists that have contributed to the growth of the market at a CAGR of 1.27% during the forecasting years of 2019-2027.

MARKET INSIGHTS

The regional market study of North America covers the analysis of the United States and Canada economy, which further reveals that North America reaps the highest amount of revenue among other regions for antidepressants drugs, devices, and therapies market. The region is known to include the United States which has the highest number of patients diagnosed with clinical depression. The US market for antidepressants drugs, devices, and therapies driven by strict regulatory implications. Establishment of generic drug makers in the market poses a great challenge for the branded manufacturers as the loss of patents is a regular occurrence in the market.

COMPETITIVE INSIGHTS

Some of the competing antidepressants drug manufacturing market players are Brainsway, F. Hoffmann-La Roche Ltd., Neuronetics, Allergan PLC, Boehringer Ingelheim GmbH, Eli Lilly and Company, H. Lundbeck AS, GlaxoSmithKline, Pfizer, Mayo Clinic and Abbot Laboratories.


1. Research Scope
1.1. Study Goals 1.2. Scope Of The Market Study 1.3. Who Will Find This Report Useful? 1.4. Study And Forecasting Years
2. Research Methodology
2.1. Sources Of Data 2.1.1. Secondary Data 2.1.2. Primary Data 2.2. Top-down Approach 2.3. Bottom-up Approach 2.4. Data Triangulation
3. Executive Summary
3.1. Market Summary 3.2. Key Findings 3.2.1. Serotonin And Norepinephrine Reuptake Inhibitors (Snris) Is The Dominant Drug In Antidepressants Market3.2.2. Deep Brain Stimulator Is Expected To Grow Fast Among Other Devices Over The Forecast Period 3.2.3. Cognitive Behavior Therapy (Cbt) Is The Largest Contributor To Antidepressants Therapies Market
4. Market Dynamics
4.1. Market Definition & Scope 4.2. Market Drivers 4.2.1. Rise In The Number Of Depression Patients 4.2.2. Increase In Aging Population 4.2.3. Rising Consciousness Of Depression As A Medical Disorder 4.2.4. Surge In Sales Of Antidepressants 4.3. Market Restraints 4.3.1. High Cost Of Depression Therapy 4.3.2. Patent Expiration Faced By The Companies 4.3.3. Delay In Product Launches 4.4. Market Opportunities 4.4.1. Huge Market Potential 4.4.2. More Preference For Personnel Therapy & Device Treatment 4.5. Market Challenges 4.5.1. Stiff Competition From The Generic Drugmakers
5. Market By Antidepressants Drugs
5.1. Serotonin And Norepinephrine Reuptake Inhibitors (Snris)5.2. Tricyclic Antidepressants (Tca) 5.3. Monoamine Oxidase Inhibitors (Maois) 5.4. Atypical Antidepressants 5.5. Selective Serotonin Reuptake Inhibitors 5.6. Benzodiazepines 5.7. Anticonvulsants 5.8. Beta-blockers 5.9. Other Antidepressants Drugs
6. Market By Devices
6.1. Deep Brain Stimulators 6.2. Fisher Wallace Stimulators 6.3. Transcranial Magnetic Stimulator 6.4. Other Devices
7. Market By Therapies
7.1. Cognitive Behavior Therapy (Cbt) 7.2. Electroconvulsive Therapy (Ect) 7.3. Rational Emotive Behavior Therapy (Rebt) 7.4. Other Therapies
8. Key Analytics
8.1. Porter’s Five Force Model 8.1.1. Threat Of New Entrants 8.1.2. Threat Of Substitute 8.1.3. Bargaining Power Of Suppliers 8.1.4. Bargaining Power Of Buyers 8.1.5. Threat Of Competitive Rivalry 8.2. Opportunity Matrix 8.3. Vendor Landscape 8.4. Value Chain Analysis 8.4.1. For Drugs 8.4.2. For Devices 8.5. Key Buying Criteria
9. Geographical Analysis
9.1. North America 9.1.1. United States 9.1.2. Canada
10. Competitive Landscape
10.1. Market Share Analysis10.2. Company Profile 10.2.1. Abbot Laboratories 10.2.2. Allergan Plc 10.2.3. Boehringer Ingelheim Gmbh 10.2.4. Brainsway 10.2.5. Eli Lilly And Company 10.2.6. F. Hoffmann-la Roche Ltd. 10.2.7. Glaxosmithkline 10.2.8. H. Lundbeck As 10.2.9. Mayo Clinic 10.2.10. Neuronetics 10.2.11. Pfizer
List Of Tables
Table 1 North America Antidepressants Drugs, Devices And Therapies Market, By Country, 2019-2027, (In $ Million) Table 2 Landscape Of Drug Expiry And Launches In The United States Table 3 North America Antidepressants Drugs, Devices And Therapies Market, By Antidepressants Drugs, 2019-2027, (In $ Million) Table 4 North America Antidepressants Drugs, Devices And Therapies Market, By Devices, 2019-2027, (In $ Million) Table 5 North America Antidepressants Drugs, Devices And Therapies Market, By Therapies, 2019-2027, (In $ Million) Table 6 Opportunity Matrix Table 7 Vendor Landscape Table 8 North America Antidepressants Drugs, Devices And Therapies Market, By Country, 2019-2027 (In $ Million)
List Of Figures
Figure 1 North America Antidepressants Drugs, Devices And Therapies Market Share, By Drugs, 2018 & 2027 (%) Figure 2 Snris Market, 2019 - 2027 (In $ Million) Figure 3 Deep Brain Stimulators Market, 2019-2027 (In $ Million) Figure 4 Cognitive Behavior Therapy (Cbt) Market ($ Million) Figure 5 North America Antidepressants Drugs, Devices And Therapies Market, By Cognitive Behavior Therapy (Cbt), 2019-2027, (In $ Million) Figure 6 North America Antidepressants Drugs, Devices And Therapies Market, By Electroconvulsive Therapy (Ect), 2019-2027, (In $ Million) Figure 7 North America Antidepressants Drugs, Devices And Therapies Market, By Rational Emotive Behavior Therapy (Rebt), 2019-2027, (In $ Million) Figure 8 North America Antidepressants Drugs, Devices And Therapies Market, Other Therapies, 2019-2027, (In $ Million) Figure 9 Porter’s Five Force Model Figure 10 Value Chain Of Antidepressant Drugs Figure 11 Value Chain Analysis For Device Market Figure 12 North America Antidepressants Drugs, Devices And Therapies Market, Regional Outlook, 2018 & 2027, (%) Figure 13 United States Antidepressants Drugs, Devices And Therapies Market, 2019-2027 (In $ Million) Figure 14 Canada Antidepressants Drugs, Devices And Therapies Market, 2019-2027 (In $ Million Figure 15 Market Share Of Antidepressants Drug Manufacturers (Percentage Of Sales), 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report